Qualcomm extends its medical device network to Europe
Qualcomm ($QCOM) is launching its 2net platform in Europe, a system designed to connect wireless medical devices to a cloud-based data hub.
The company launched the service stateside last year, allowing devices to stream encrypted patient data to a secure host accessible by physicians and specialists. Qualcomm is extending the program to Europe in response to client demand, furthering its goal of creating a worldwide network of medical data that will improve patient outcomes, Vice President Rick Valencia said in a statement.
The 2net platform is cleared as a Class I device in the EU and approved by the FDA as a Medical Device Data System, the company said. More than 40 devicemakers, app developers and payers are either enrolled or considering joining the program, Qualcomm says.
"There is a clear imperative for health services providers and manufacturers to invest in remote monitoring solutions to improve patient outcomes and align with preventive care initiatives," Qualcomm Life Managing Director Laurent Vandebrouck said in a statement. "Qualcomm Life has been helping its customers pave the way for wireless health in the U.S., and this is an exciting time to extend our services and offering in Europe."
The demand for wireless medical devices has been on the rise of late, as developers look to integrate cloud-based data storage with implantable devices and patient monitors. In response, the Federal Communications Commission this year approved a designated wireless spectrum for monitoring devices called mobile body area networks, and GE Healthcare ($GE) and Philips Healthcare ($PHG) are among the manufacturers looking to commercialize the wireless technology.
- read Qualcomm's release